ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

New Screening Tool Helps GP ID Hereditary BC Risk

October 27, 2006

Hospice Assn. Meeting Planned for April

January 24, 1986

In Brief: House Passes appropriations Bill; Senate Markup in Late Summer; Kirschstein Acting NIH Director

July 9, 1993

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994

Women Surgeons: We Need Answers On Tamoxifin Now

May 13, 1994